Instructions

Instruction for Authors

 

Authors submiting manuscripts to JBAD do so on the understanding that the work has not been published previously, is not being considered for publication elsewhere, and has been read and approved by all authors. Further, submission of manuscripts means that authors automatically agree to sign a Copyright Form and upload it from its website. The articles could be submitied as soft copy with CD, pen drive,email (acadbd@yahoo.com) or through online in our website.

 

The journal levies no fees for submission, publication and processing. Articles are accepted in the following sections (all word limits exclude abstract and references):

 

Editorials:

 

These are usually solicited, contributed by editorial board members, but unsolicited material may also be considered (approx. 1000 to 1200 words). A maximum of 12 references may be included. Editorials should normally not have tables and figures.

Reviews:

 

The journal is particularly keen to publish concise, high-quality review articles with systematic critical assessments of literature and data sources. Review articles may be solicited by the Editor or may be submitied by authors for publication subject to peer review. The word count of the body text should not exceed 3000 words and should include an unstructured abstract (maximum 290 words) with key 3-5 words.

Original articles:

This includes reports of trials, studies of diagnostic tests or surveys. Original articles must include a structured abstract of 250 words with 5 headings: Background, Aims, Methods, Results, and Conclusion with 3-5 key words. Body text of article should include an Introduction, Methods, Results, Discussion, Acknowledgement if any, References, legends to figures, and tables with a word count limit of 3000 words.Double blind controlled trials must follow the CONSORT statement and observational studies must follow the STROBE guidelines. The articles would not be considered without submission of a completed CONSORT or STROBE checklist. Registration of clinical trials is desirable. Permission from ethics commitiee/ Institutional Review Board (IRB) and statement of sources of support and conflict of interest are mandatory for all studies. IRB approval must be mentioned in the “methods” section of all manuscripts.

Short communication:

Reports data on research projects that have progressed to a point where important preliminary observations should be disseminated. A “Summary and Significance” are required in the beginning of the article as “Abstract” of 250 words with 3-5 key words. It may be organized into Introduction, Methods, Results, and Discussion sections. Communications will be processed for rapid publication within journal production schedules. The word limit is of 2000 and a maximum of three figures/tables/illustrations are permissible.

Case reports:

Reports of extraordinary significance of a disease or a new disease are considered. Case reports must include an unstructured abstract (not more than 190 words) with 3-5 key words and should not exceed 1000 words of body text with up to 10 references. The article should be divided into Introduction, Case report(s), Discussion and References. Suitable figures and tables (maximum two) can be added.

The clinical picture:

1. An optimal clinical picture contributes to visual information that will be useful to other physicians.

2. The purpose of this section is to provide high quality images to illustrate an important dermatological disorder, which should be interesting and educational. Good images relevant to daily practice are welcome.

3. Most formats are acceptable, including JPEG (preferable), TIFF, BMP, GIF, Adobe Photoshop, Adobe Illustrator. The most important factor is that the images are clear (at least 1-4 MB in size) and of not less than 300 dpi.

4. A brief description regarding the patient history and the condition,management must be provided. (around 500 words) A maximum of 2 latest references may be given. A maximum of three authors can be considered for this section.

Therapeutic Pearls:

This section is for reporting innovative approach in management of dermatological disorders. It may include newer, therapeutic measures and/or author’s modifications in the existing modalities of treatment. Manuscript should not be more than 750 words with 5 references. Manuscript should include high resolution pre and post treatment clinical pictures along with the proposed mechanism of action of the reported therapeutic modality. This section can have maximum of three authors. Following points needs to be kept in mind while submiting manuscripts in this section:

o At least two clinical images should be submitted, pre and post treatment, clearly indicating the change atier treatment. Images must be in jpeg or jpg format, minimum 300 dpi.

o The mechanism of action of the reported modality should be mentioned or logical explanation should be given.

o The utility of newer technique in comparison to conventional treatment modality should either be evident by clinical response or should be explained in manuscript.

• Letters to the editor: Letters to the Editor (Correspondence) may be in response to issues arising from recently published articles, or short free-standing pieces expressing an opinion. These should be formatied in one continuous section, normally be no more than 750 words in length, may have up to 5 references and a maximum of three photographs. No abstract is required.

• History: An article (up to 2500 words in length) on the history of pigmentary disorder, also a biographic account of a historic or noteworthy figure in dermatology. No abstract is required.

• Perspective: An article of 500-1000 words length with 0- 5 references on matters of interest to readers may be submitied. The author may express his or her opinion without complete documentation. No abstract is required.

• Focus: Short reviews (up to 1500 words) on instruments, equipment, drugs or procedures of dermatological disorders may be submitied atier consulting the editor on the selection of subject. No abstract is required.

• Dermatological surgery: An article relating to the surgical aspects of treatment. Article types may include Review, Report or Case Report Format.

• Spot the diagnosis: A classic clinical case with short history, examination, one to three good photographs and investigation findings (up to 150 words). It should be followed by the answer in the form of the diagnosis and a short review of the condition. Manuscripts submitied for this section could be authored by not more than four authors and could include up to 500 words excluding references. It could have up to 5 references.

• Concept: It focuses discussion of a specific question, emerging problem, or a controversial topic. Concept is expected to provide a data-based view and is otien solicited from few contributors to allow coverage from different expertise.

• Hypothesis: A brief report offering a novel hypothesis for solving existing problem. These need not always be based on an existing data.

Manuscript format

Original articles should be divided into following sections: Title page, Abstract, Text, Acknowledgement, References, Tables with titles and footnotes, alternatively Graphs with titles and Illustrations with legends. Each of the sections is to start on a separate page. Pages should be numbered consecutively beginning from the abstract.

Title page:

• Title of the article

• Names of all authors with their institutional affiliations

• Name of the corresponding author with contact address, telephone number, Email address

• Disclosure of conflict of interest if any

• Disclosure of sources of funding or sponsor

• Word count of abstract

Abstract:

• Authors name should not be given

• Preferably within about 200 words

• Avoid abbreviations in the title and abstract except standard abbreviation

Text:

Text should be arranged into following sections: Introduction, Materials and Methods, Results, Discussion, Acknowledgement and References

Introduction:

• Statement of the problem with a short discussion of its importance and significance

• Review of the literature related to the problem with pertinent reference

• Objectives/hypothesis/benefits expected stated in 1-2 paragraphs

Materials and Methods:

• Study type, place and time

• Description of study variables

• Description of study subjects and grouping

• Selection criteria

• Approval of the study involving human subjects by ethical review commitiee and description of the ethical aspects in such study • Description of procedure, methods, apparatus, drugs or chemicals as applicable

• Description of statistical procedure with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results

Results:

• Present result in logical sequence in text, table and illustration with most important finding first

• Describe without comment

• Restrict number of tables and figures needed to support assessment of paper

• Do not duplicate data in tables and figures

Tables:

• Simple, self explanatory with brief title, not duplicated in text

• Each table should be numbered in Romans and printed in separate page

• Do not use internal horizontal and vertical rules

• Use of many tables is not encouraged

Illustration:

• All illustrations must be numbered consecutively in Arabic numerals as they appear in the text

• Submit print photograph of each illustration along with its electronic file

• Figure number, title of manuscript, name of the corresponding author and arrow indicating top should be writien on a sticky label affixed on the back of each photograph

• Scanned picture, graph, chart with title and figure number should be printed on separate page and its original data presentation file should be inserted in the CD along with text

Legend:

• Must be typed on a separate sheet of paper

• Photomicrograph should indicate the magnification, internal scale and the method of staining

• All drugs should be mentioned in their generic form. The commercial name may be used in parenthesis

Acknowledgement:

• Individuals, institution, sponsor, organization or bodies can be acknowledged in the article for their contribution or financial or any form of assistance to the work

References:

• For reference, use author number style (Vancouver) which is based on an ANSI standard adapted by the National Library of Medicine(NLM)

• References should be numbered consecutively in the order in which they are first mentioned in the text • Identify references in the text, tables and legends by Arabic numerals in superscript

• All citations to electronic references should be presented in numbered references following the text

• The titles of the journals should be abbreviated according to the style used in Index Medicus

• Write names of 3 authors followed by et al. ifauthors’ number is more than three.

• The reference list is not usually checked by the editorial staff or reviewer. It is the total responsibility of author to provide accurate information.

Citation rules:

Citation style by Journal of American Academy of Medicine (JAMA) is followed and it is available in https://guides.med.ucf.edu/ld.php?con - tent_id=58246564.